Catherine Ramsey
Stock Analyst at Baird
(4.63)
# 235
Out of 4,749 analysts
39
Total ratings
65.52%
Success rate
21.74%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TWST Twist Bioscience | Maintains: Outperform | $46 → $48 | $52.37 | -8.34% | 5 | Nov 19, 2024 | |
| NTRA Natera | Maintains: Outperform | $120 → $160 | $176.92 | -9.56% | 5 | Nov 13, 2024 | |
| ILMN Illumina | Maintains: Neutral | $124 → $139 | $132.74 | +4.72% | 4 | Nov 6, 2024 | |
| RVTY Revvity | Maintains: Outperform | $136 → $138 | $126.13 | +9.41% | 3 | Nov 5, 2024 | |
| CSTL Castle Biosciences | Maintains: Outperform | $37 → $39 | $28.27 | +37.96% | 7 | Nov 5, 2024 | |
| WAT Waters | Maintains: Neutral | $319 → $312 | $415.48 | -24.91% | 7 | May 8, 2024 | |
| TMO Thermo Fisher | Maintains: Outperform | $695 → $665 | $597.75 | +11.25% | 2 | Nov 1, 2022 | |
| A Agilent Technologies | Maintains: Outperform | $155 → $160 | $151.52 | +5.60% | 5 | Aug 17, 2022 | |
| EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $56.05 | +33.81% | 1 | Aug 3, 2022 |
Twist Bioscience
Nov 19, 2024
Maintains: Outperform
Price Target: $46 → $48
Current: $52.37
Upside: -8.34%
Natera
Nov 13, 2024
Maintains: Outperform
Price Target: $120 → $160
Current: $176.92
Upside: -9.56%
Illumina
Nov 6, 2024
Maintains: Neutral
Price Target: $124 → $139
Current: $132.74
Upside: +4.72%
Revvity
Nov 5, 2024
Maintains: Outperform
Price Target: $136 → $138
Current: $126.13
Upside: +9.41%
Castle Biosciences
Nov 5, 2024
Maintains: Outperform
Price Target: $37 → $39
Current: $28.27
Upside: +37.96%
Waters
May 8, 2024
Maintains: Neutral
Price Target: $319 → $312
Current: $415.48
Upside: -24.91%
Thermo Fisher
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $597.75
Upside: +11.25%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $151.52
Upside: +5.60%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $56.05
Upside: +33.81%